HealthCare Global Enterprises Valuation Multiples

HealthCare Global Enterprises is valued at $928M as of October 2026, a 3.7x revenue multiple. In the last 12 months, HealthCare Global Enterprises revenue was $286M and HealthCare Global Enterprises EBITDA was $54M.

HealthCare Global Enterprises Overview

About HealthCare Global Enterprises

HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company’s operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.


Founded

1998

HQ

India

Employees

5.8K

Financials (LTM)

Revenue: $286M
EBITDA: $54M

EV

$1.1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

HealthCare Global Enterprises Financials

HealthCare Global Enterprises reported last 12-month revenue of $286M and EBITDA of $54M.

In the same LTM period, HealthCare Global Enterprises generated $210M in gross profit, $54M in EBITDA, and $8M in net income.

Revenue (LTM)


HealthCare Global Enterprises P&L

In the most recent fiscal year, HealthCare Global Enterprises reported revenue of $265M and EBITDA of $45M.

HealthCare Global Enterprises is profitable as of last fiscal year, with gross margin of 50%, EBITDA margin of 17%, and net margin of 1%.

See analyst estimates for HealthCare Global Enterprises
LTMLast FY202320242025202620272028
Revenue$286M$265M$192M$222M$256M
Gross Profit$210M$133M$100M$113M$128M
Gross Margin73%50%52%51%50%
EBITDA$54M$45M$34M$40M$44M
EBITDA Margin19%17%17%18%17%
EBIT Margin10%9%9%8%9%
Net Profit$8M$1M$5M$5M$2M
Net Margin3%1%2%2%1%
Net Debt-$46M---

Financial data powered by Morningstar, Inc.

HealthCare Global Enterprises Stock Performance

HealthCare Global Enterprises has current market cap of $928M, and enterprise value of $1.1B.

Market Cap Evolution


HealthCare Global Enterprises' stock price is $6.21.

HealthCare Global Enterprises share price decreased by 10.6% in the last 30 days, and by 25.8% in the last year.

HealthCare Global Enterprises has an EPS (earnings per share) of $0.01.

See more trading valuation data for HealthCare Global Enterprises
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.1B$928M0.7%-10.6%-11.8%-25.8%$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

HealthCare Global Enterprises Valuation Multiples

HealthCare Global Enterprises trades at 3.7x EV/Revenue multiple, and 19.5x EV/EBITDA.

See NTM and 2027E valuation multiples for HealthCare Global Enterprises

EV / Revenue (LTM)


HealthCare Global Enterprises Financial Valuation Multiples

As of October 16, 2026, HealthCare Global Enterprises has market cap of $928M and EV of $1.1B.

HealthCare Global Enterprises has a P/E ratio of 109.6x.

LTMLast FY202320242025202620272028
EV/Revenue3.7x4.0x5.5x4.8x4.2x
EV/EBITDA19.5x23.8x31.6x26.6x24.2x
EV/EBIT38.5x45.5x63.3x56.5x47.6x
EV/Gross Profit5.1x8.0x10.6x9.4x8.3x
P/E109.6xn/m203.9x195.4xn/m
EV/FCF154.8x(90.1x)n/m(241.4x)(105.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified HealthCare Global Enterprises Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

HealthCare Global Enterprises Margins & Growth Rates

HealthCare Global Enterprises grew revenue by 15% and EBITDA by 33% in the last fiscal year.

In the most recent fiscal year, HealthCare Global Enterprises reported gross margin of 50%, EBITDA margin of 17%, and net margin of 1%.

See estimated margins and future growth rates for HealthCare Global Enterprises

HealthCare Global Enterprises Margins

Last FY202420252026202720282029
Gross Margin50%51%50%68%
EBITDA Margin17%18%17%19%
EBIT Margin9%8%9%10%
Net Margin1%2%1%4%
FCF Margin(4%)(2%)(4%)2%

HealthCare Global Enterprises Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth15%16%15%16%
Gross Profit Growth70%14%13%58%
EBITDA Growth33%19%10%27%
EBIT Growth33%12%19%30%
Net Profit Growth854%4%(53%)378%
FCF Growth(184%)427%130%(145%)

Data powered by FactSet, Inc. and Morningstar, Inc.

HealthCare Global Enterprises Operational KPIs

HealthCare Global Enterprises' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

HealthCare Global Enterprises' Rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

HealthCare Global Enterprises' Rule of X is 58% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for HealthCare Global Enterprises
LTMLast FY202320242025202620272028
Rule of 4034%35%---
Bessemer Rule of X57%58%---
Revenue per Employee-$0.0M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-2%2%2%2%
G&A Expenses to Revenue-0%4%3%1%
Opex to Revenue-41%43%43%41%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

HealthCare Global Enterprises Competitors

HealthCare Global Enterprises competitors include Infracore, Al Hammadi Holding, Dr. Sulaiman Al Habib Medical Services, Thomson Medical, Clinica Baviera, Terveystalo, Park Medi World, Life Healthcare Group, Rhoen Klinikum and WELL Health.

Most HealthCare Global Enterprises public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Infracore$29K-34549.4x---
Al Hammadi Holding$329M$98M3.1x2.9x10.4x11.2x
Dr. Sulaiman Al Habib Medical Services$410M$110M2.7x-9.9x-
Thomson Medical$328M$52M5.6x5.4x34.8x26.6x
Clinica Baviera$338M$95M2.8x2.6x9.9x9.0x
Terveystalo$1.4B$259M1.1x1.2x6.3x6.4x
Park Medi World$174M$47M6.2x5.2x23.0x20.1x
Life Healthcare Group$1.5B$54M0.9x0.9x24.7x5.4x

This data is available for Pro users. Sign up to see all HealthCare Global Enterprises competitors and their valuation data.

Start Free Trial

Acquisitions by HealthCare Global Enterprises

HealthCare Global Enterprises has acquired 3 companies to date.

Last acquisition by HealthCare Global Enterprises was on June 28th 2024. HealthCare Global Enterprises acquired Mahatma Gandhi Cancer Hospital & Research Institute for $50M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by HealthCare Global Enterprises

Mahatma Gandhi Cancer Hospital & Research Institute
Suchirayu Healthcare Solutions
Cancer Care Kenya
Description
Mahatma Gandhi Cancer Hospital & Research Institute is a Visakhapatnam-based facility offering comprehensive oncology services including surgical resection, chemotherapy, and radiation therapy. Established in 1971, the 425-bed institute treats over 100,000 patients yearly with diagnostics like PET-CT and symptom palliation programs. Affiliated with academic programs, it conducts clinical trials in South India.
Suchirayu Healthcare Solutions operates a 250-bed multi-super specialty tertiary care hospital in Hubli, North Karnataka, India. Established to deliver affordable quality healthcare, it offers services in cardiology, neurology, orthopedics, and oncology, equipped with advanced diagnostic and surgical facilities serving regional populations.
Cancer Care Kenya is a Nairobi-based comprehensive cancer center founded in 2010, treating over 1,000 patients annually including 200 internationals from East Africa. The facility offers radiotherapy with Varian TrueBeam, chemotherapy, and brachytherapy in a 5,000-square-meter site. Staff speak English, Swahili, Hindi, and Gujarati, partnering with Aga Khan University for training. Cancer Care Kenya introduced PET-CT scanning in 2018, expanding palliative services.
HQ CountryIndiaIndiaKenya
HQ City
Visakhapatnam
Bangalore
Nairobi
Deal Date28 Jun 202422 Nov 20215 Apr 2017
Valuation$50M$1M$900K
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all HealthCare Global Enterprises acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About HealthCare Global Enterprises

When was HealthCare Global Enterprises founded?HealthCare Global Enterprises was founded in 1998.
Where is HealthCare Global Enterprises headquartered?HealthCare Global Enterprises is headquartered in India.
How many employees does HealthCare Global Enterprises have?As of today, HealthCare Global Enterprises has over 5K employees.
Who is the CEO of HealthCare Global Enterprises?HealthCare Global Enterprises' CEO is Manish Mattoo.
Is HealthCare Global Enterprises publicly listed?Yes, HealthCare Global Enterprises is a public company listed on National Stock Exchange of India.
What is the stock symbol of HealthCare Global Enterprises?HealthCare Global Enterprises trades under HCG ticker.
When did HealthCare Global Enterprises go public?HealthCare Global Enterprises went public in 2016.
Who are competitors of HealthCare Global Enterprises?HealthCare Global Enterprises main competitors include Infracore, Al Hammadi Holding, Dr. Sulaiman Al Habib Medical Services, Thomson Medical, Clinica Baviera, Terveystalo, Park Medi World, Life Healthcare Group, Rhoen Klinikum, WELL Health.
What is the current market cap of HealthCare Global Enterprises?HealthCare Global Enterprises' current market cap is $928M.
What is the current revenue of HealthCare Global Enterprises?HealthCare Global Enterprises' last 12 months revenue is $286M.
What is the current revenue growth of HealthCare Global Enterprises?HealthCare Global Enterprises revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of HealthCare Global Enterprises?Current revenue multiple of HealthCare Global Enterprises is 3.7x.
What is the current EBITDA of HealthCare Global Enterprises?HealthCare Global Enterprises' last 12 months EBITDA is $54M.
What is HealthCare Global Enterprises' EBITDA margin?HealthCare Global Enterprises' last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of HealthCare Global Enterprises?Current EBITDA multiple of HealthCare Global Enterprises is 19.5x.
What is the current FCF of HealthCare Global Enterprises?HealthCare Global Enterprises' last 12 months FCF is $7M.
What is HealthCare Global Enterprises' FCF margin?HealthCare Global Enterprises' last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of HealthCare Global Enterprises?Current FCF multiple of HealthCare Global Enterprises is 154.8x.
How many companies HealthCare Global Enterprises has acquired to date?As of October 2026, HealthCare Global Enterprises has acquired 3 companies.
What was the largest acquisition by HealthCare Global Enterprises?$50M acquisition of Mahatma Gandhi Cancer Hospital & Research Institute on 28th June 2024 was the largest M&A HealthCare Global Enterprises has done to date.
What companies HealthCare Global Enterprises acquired?HealthCare Global Enterprises acquired Mahatma Gandhi Cancer Hospital & Research Institute, Suchirayu Healthcare Solutions, and Cancer Care Kenya.
In how many companies HealthCare Global Enterprises has invested to date?HealthCare Global Enterprises hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to HealthCare Global Enterprises

Lists including HealthCare Global Enterprises

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial